Product Information

VIMPAT 10 MG/ML SOLUTION is a brand product labeled by UCB, Inc., priced at $2.2882 per ML under NDC 00131541072. Its NADAC has been published 305 times since Aug 26, 2020.

The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

VIMPAT 10 MG/ML SOLUTION

lacosamide
$2.2882per ML
High Outlier
DEA Schedule CV

Strength

10 mg/mL

Manufacturer

UCB, Inc.

NDC

00131541072

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LACOSAMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022255

On Market Since

4/20/2010

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for VIMPAT 10 MG/ML SOLUTION has been published 305 times since Aug 26, 2020, and over the history we have for it it has risen 29.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.2882 per ML
All-time high$2.2997 (May 13, 2026)
All-time low$1.7620 (Aug 26, 2020)
52-week high$2.2997
52-week low$2.2414
Median price$2.1003
Average price$2.0717
Largest weekly change+6.9% (Jan 12, 2022)
Weeks tracked305
Tracking sinceAug 26, 2020

Price History

1W

0.0%

1M

0.0%

3M

-0.5%

6M

+2.1%

1Y

+1.6%

3Y

+8.9%

5Y

+23.7%

All

+29.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lacosamide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of VIMPAT 10 MG/ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for VIMPAT 10 MG/ML SOLUTION, manufactured by UCB, Inc., is $2.2882 per ML (NDC 00131541072), effective Jun 24, 2026.

How has the price of VIMPAT 10 MG/ML SOLUTION changed over time?

Over the history we have for it, the NADAC for VIMPAT 10 MG/ML SOLUTION has risen 29.9%. It has been tracked across 305 weekly CMS publications since Aug 26, 2020.

What are the highest and lowest recorded NADAC prices for VIMPAT 10 MG/ML SOLUTION?

Since Aug 26, 2020, the NADAC for VIMPAT 10 MG/ML SOLUTION has ranged from a low of $1.7620 (Aug 26, 2020) to a high of $2.2997 (May 13, 2026), with a median of $2.1003 per ML.

Are there cheaper alternatives to VIMPAT 10 MG/ML SOLUTION?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VIMPAT 10 MG/ML SOLUTION, so no direct lower-cost alternative is listed.

Who manufactures VIMPAT 10 MG/ML SOLUTION?

VIMPAT 10 MG/ML SOLUTION (NDC 00131541072) is labeled by UCB, Inc., and CMS classifies it as a brand product.